IP Library › Granted Patent US 8,268,828
Granted Patent B2
US 8,268,828 · App. 12/852,076 · Granted Sep 18, 2012

Inhibitors of the chemokine receptor CxCR3

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,268,828
App. No.
12/852,076
Granted
Sep 18, 2012
Kind
B2
Abstract

This invention is directed to a 3-(amido or sulphamido)-4-(4-substituted-azinyl)benzamide or benzsulphonamide compound as defined herein. The 3-(amido or sulphamido)-(4-substituted-azinyl)benzamide or benzsulphonamide compound is useful as a inhibitor of the chemokine receptor CxCR3, and for preventing or treating a CxCR3 chemokine receptor mediated disease or condition related thereto in a patient in need of such.

Claims (3)

1. A compound selected from the group consisting of the following formulae:

or a pharmaceutically acceptable salt, N-oxide or any combination thereof.

2. A pharmaceutical composition comprising a pharmaceutically acceptable amount of a compound according to claim 1 , and a pharmaceutically acceptable additive.

Assignments (3)
CHANGE OF NAME Recorded Aug 2, 2011
From: SANOFI-AVENTIS
To: SANOFI
Reel/Frame 026686/0522 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 29, 2011
From: THORPE, DAVID S.; SMRCINA, MARTIN; CABEL, DAGMAR D.
To: SANOFI-AVENTIS
Reel/Frame 026671/0974 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 9, 2011
From: THORPE, DAVID S.; SMRCINA, MARTIN; CABEL, DAGMAR D.
To: SANOFI-AVENTIS
Reel/Frame 026415/0193 →